On recordAs of Nov 11, 2026
Director Ronald W. Tysoe sold $872K on Jul 22, 2026.
One open-market sale reported on Form 4.

Insider and Congress filings
Specialty Business Services, listed on NASDAQ.
S&P 500 · Nasdaq 100 · 399 insider transactions · 64 Congress trades · last filed Oct 29, 2026
Free on iOS and Android
Email me new Cintas filings
An email on days Cintas insiders file a trade or Cintas reports results. One a day at most.
Check your inbox
We sent a link to your address. Tap it to confirm; we email nothing until you do.
Want it the moment it is filed? The app sends a push, free.
On recordAs of Nov 11, 2026
Director Ronald W. Tysoe sold $872K on Jul 22, 2026.
One open-market sale reported on Form 4.
EarningsQ1 FY2027 · reported Sep 23, 2026
Q1 FY2027: Beat +3.0% on adjusted EPS. Revenue came in line. Next report Dec 17, 2026.
EPS Q1 FY2027
Revenue Q1 FY2027
Beat 3 · In line 3
EPS against the consensus, quarter by quarter. Outlined: a GAAP figure against an adjusted consensus.
Consensus $1.36 a share on $3.03B of revenue, the analysts’ forecast.
Every quarterMoney managers13F filings for Jun 30, 2026
institutions reported Cintas shares in 13F filings for Jun 30, 2026. BlackRock, Inc. held the largest stake, $4.5B.
The largest holders
Insider tradesForm 4 · 3 open-market filings shown
Three open-market sales.
Apr 20, 2026Jul 22, 2026
Sales
A median 2 business days from trade to filing. Form 4 is due within two.
Every filingCongressSTOCK Act disclosures to the House and Senate
20 Congress disclosures shown, from 4 members.
4 members of Congress report a position in CTAS, by our estimate. Who holds it
Every Congress trade in CTASEvery disclosure| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2027reported Sep 23, 2026 | $1.39 | $1.35 | $3.0B | $3.0B | EPS beatRevenue in line |
| Q4 FY2026reported Jul 15, 2026 | $1.29 | $1.24 | $2.9B | $2.9B | EPS beatRevenue in line |
| Q3 FY2026reported Mar 25, 2026 | $1.24 | $1.24 | $2.8B | $2.8B | EPS in line, GAAPRevenue in line |
| Q2 FY2026reported Dec 18, 2025 | $1.21 | $1.20 | $2.8B | $2.8B | EPS in line, GAAPRevenue in line |
| Q1 FY2026reported Sep 24, 2025 | $1.20 | $1.19 | $2.7B | $2.7B | EPS in line, GAAPRevenue in line |
| Q4 FY2025reported Jul 17, 2025 | $1.09 | $1.07 | $2.7B | $2.6B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
No earnings call briefs on CTAS yet. Briefs from every company we cover.
Past year Each firm's latest target, newest first
| Firm | Rating | Target | Action | Date |
|---|---|---|---|---|
| BofA Securities | Buyrated Jul 16, 2026 | $232 | Target set | |
| Argus | Buy | $240 | Target set | |
| Baird | Outperform | $222 | Raised from $214 | |
| UBS | Buy | $230 | Raised from $228 | |
| Wells Fargo | Overweight | $250 | Raised from $245 | |
| Goldman Sachs | Not stated | $231 | Target set | |
| Morgan Stanley | Equal Weight | $210 | Target set | |
| Rothschild & Co Redburn | Neutral | $184 | Target set |
Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
4 other firms rated CTAS in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 11, 2026.
| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Todd M. SchneiderChief Executive Officer | $1.2M | $7.9M | $3.1M | $12.2M |
| James N. RozakisPresident and Chief Operating Officer | $800K | $1.5M | $3.1M | $5.3M |
| Scott A. GarulaExecutive Vice President and Chief Financial Officer | $650K | $1.5M | $1.2M | $3.3M |
| D. Brock DentonExecutive Vice President, General Counsel and Secretary | $579K | $728K | $1.7M | $3.0M |
| Scott D. FarmerExecutive Chairman of the Board | $750K | $180K | $63K | $993K |
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. Executives who have since left are not shown. Read the filing
| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $4.5B | 26,578,230 | -1.5% | 6.64% |
| Vanguard Capital Management LLC | $3.8B | 22,210,590 | +0.6% | 5.55% |
| State Street Corp | $2.7B | 15,818,329 | +2.8% | 3.94% |
| Invesco Ltd. | $2.3B | 13,578,341 | +61.8% | 3.39% |
| Vanguard Portfolio Management LLC | $2.3B | 13,447,131 | +1.1% | 3.36% |
| Geode Capital Management, LLC | $1.6B | 9,549,575 | +0.3% | 2.39% |
| FMR LLC | $1.1B | 6,323,643 | -8.8% | 1.58% |
| T. Rowe Price Associates, Inc. | $978.1M | 5,750,996 | +0.2% | 1.44% |
| Goldman Sachs Group Inc | $799.1M | 4,698,626 | +19.4% | 1.17% |
| Norges Bank | $741.8M | 4,361,704 | New | 1.09% |
| Morgan Stanley | $723.4M | 4,253,139 | +0.4% | 1.06% |
| Fort Washington Investment Advisors Inc | $723.3M | 4,252,487 | 0.0% | 1.06% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Ronald W. TysoeDirector | Sold | 4,363 | $199.90 | $872K | Jul 22, 2026filed Jul 23, 2026 | 1d |
| Melanie W. BarstadDirector | Sold | 9,142 | $202.94 | $1.9M | Jul 16, 2026filed Jul 20, 2026 | 2d |
| Ronald W. TysoeDirector | Sold | 4,666 | $178.87 | $835K | Apr 20, 2026filed Apr 22, 2026 | 2d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
| Insider | Event | Shares | Date |
|---|---|---|---|
| Ronald W. TysoeDirector | Stock award | 2,107 | Oct 28, 2026 |
| Robert E. ColettiDirector | Stock award | 2,107 | Oct 28, 2026 |
| Robert E. ColettiDirector | Stock award | 116 | Oct 27, 2026 |
| Beverly K. CarmichaelDirector | Stock award | 2,107 | Oct 28, 2026 |
| Melanie W. BarstadDirector | Stock award | 148 | Oct 27, 2026 |
| Martin MucciDirector | Stock award | 2,107 | Oct 28, 2026 |
| Joseph ScaminaceDirector | Stock award | 2,107 | Oct 28, 2026 |
| Karen L. CarnahanDirector | Stock award | 2,107 | Oct 28, 2026 |
| Karen L. CarnahanDirector | Stock award | 134 | Oct 27, 2026 |
| Ronald W. TysoeDirector | Stock award | 102 | Sep 15, 2026 |
| Robert E. ColettiDirector | Stock award | 30 | Sep 15, 2026 |
| Melanie W. BarstadDirector | Stock award | 12 | Sep 15, 2026 |
| Karen L. CarnahanDirector | Stock award | 18 | Sep 15, 2026 |
| Jim RozakisPresident & COO | Tax withholding | 4,041 | Aug 10, 2026 |
| Jim RozakisPresident & COO | Stock award | 53,233 | Aug 10, 2026 |
| Jim RozakisPresident & COO | Tax withholding | 3,643 | Aug 10, 2026 |
| David Brock DentonEVP, Secretary & Gen Counsel | Stock award | 28,152 | Aug 10, 2026 |
| David Brock DentonEVP, Secretary & Gen Counsel | Tax withholding | 3,479 | Aug 10, 2026 |
| Scott GarulaEVP & CFO | Tax withholding | 2,958 | Aug 10, 2026 |
| Scott GarulaEVP & CFO | Stock award | 10,695 | Aug 10, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Stock | Purchase | $1,001 - $15,000 | +30.0% since the tradeEstimated entry price $173.31, close on Tue Jun 2Current price $225.28, close on Tue Nov 10 | Jun 2, 2026 | Jul 6, 2026 | 34d | |
| Stock | Purchase | $1,001 - $15,000 | +27.5% since the tradeEstimated entry price $176.71, close on Tue Jun 16Current price $225.28, close on Tue Nov 10 | Jun 16, 2026 | Jul 6, 2026 | 20d | |
| Stock | Sale | $1,001 - $15,000 | +32.5% since the saleEstimated exit price $170.08, close on Tue Jun 30Current price $225.28, close on Tue Nov 10 | Jun 30, 2026 | Jul 6, 2026 | 6d | |
| Stock | Purchase | $1,001 - $15,000 | +32.6% since the tradeEstimated entry price $169.86, close on Wed May 27Current price $225.28, close on Tue Nov 10 | May 27, 2026 | Jun 9, 2026 | 13d | |
| Stock | Purchase | $1,001 - $15,000 | +28.1% since the tradeEstimated entry price $175.90, close on Fri Apr 24Current price $225.28, close on Tue Nov 10 | Apr 24, 2026 | May 11, 2026 | 17d | |
| Stock | Sale | $1,001 - $15,000 | +24.3% since the saleEstimated exit price $181.21, close on Mon Mar 23Current price $225.28, close on Tue Nov 10 | Mar 23, 2026 | Apr 7, 2026 | 15d | |
| Stock | Sale | $1,001 - $15,000 | +33.6% since the saleEstimated exit price $168.66, close on Mon Mar 30Current price $225.28, close on Tue Nov 10 | Mar 30, 2026 | Apr 7, 2026 | 8d | |
| Stock | Purchase | $1,001 - $15,000 | +16.9% since the tradeEstimated entry price $192.72, close on Tue Jan 13Current price $225.28, close on Tue Nov 10 | Jan 13, 2026 | Feb 6, 2026 | 24d | |
| Stock | Sale | $1,001 - $15,000 | +18.8% since the saleEstimated exit price $189.65, close on Thu Jan 29Current price $225.28, close on Tue Nov 10 | Jan 29, 2026 | Feb 6, 2026 | 8d | |
| Stock | Sale | $1,001 - $15,000 | +23.8% since the saleEstimated exit price $182.04, close on Mon Nov 3, 2025Current price $225.28, close on Tue Nov 10 | Nov 3, 2025 | Dec 8, 2025 | 35d | |
| Stock | Sale | $1,001 - $15,000 | +21.6% since the saleEstimated exit price $185.25, close on Mon Nov 10, 2025Current price $225.28, close on Tue Nov 10 | Nov 10, 2025 | Dec 8, 2025 | 28d | |
| Stock | Sale | $1,001 - $15,000 | +10.2% since the saleEstimated exit price $204.50, close on Thu Sep 11, 2025Current price $225.28, close on Tue Nov 10 | Sep 11, 2025 | Oct 22, 2025 | 41d | |
| Stock | Sale | $1,001 - $15,000 | +12.3% since the saleEstimated exit price $200.59, close on Tue Sep 23, 2025Current price $225.28, close on Tue Nov 10 | Sep 23, 2025 | Oct 10, 2025 | 17d | |
| Stock | Sale | $1,001 - $15,000 | +10.2% since the saleEstimated exit price $204.50, close on Fri Sep 5, 2025Current price $225.28, close on Tue Nov 10 | Sep 5, 2025 | Oct 3, 2025 | 28d | |
| Stock | Purchase | $1,001 - $15,000 | +7.7% since the tradeEstimated entry price $209.14, close on Tue Oct 29, 2024Current price $225.28, close on Tue Nov 10 | Oct 29, 2024 | Sep 12, 2025 | 318d | |
| Stock | Purchase | $1,001 - $15,000 | +6.8% since the tradeEstimated entry price $210.97, close on Wed Dec 11, 2024Current price $225.28, close on Tue Nov 10 | Dec 11, 2024 | Aug 13, 2025 | 245d | |
| Stock | Sale | $15,001 - $50,000 | +4.8% since the saleEstimated exit price $214.96, close on Thu May 8, 2025Current price $225.28, close on Tue Nov 10 | May 8, 2025 | Jun 22, 2025 | 45d | |
| Stock | Sale | $50,001 - $100,000 | +3.8% since the saleEstimated exit price $216.99, close on Mon May 12, 2025Current price $225.28, close on Tue Nov 10 | May 12, 2025 | Jun 22, 2025 | 41d | |
| Stock | Purchase | $1,001 - $15,000 | +10.4% since the tradeEstimated entry price $203.99, close on Wed Apr 9, 2025Current price $225.28, close on Tue Nov 10 | Apr 9, 2025 | May 12, 2025 | 33d | |
| Stock | Purchase | $50,001 - $100,000 | +18.2% since the tradeEstimated entry price $190.54, close on Mon Apr 7, 2025Current price $225.28, close on Tue Nov 10 | Apr 7, 2025 | May 8, 2025 | 31d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in CTAS filterable by party, chamber, type and account.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Republican · House | $100,001 - $250,000 | 2.0% | |
| Republican · House | $50,001 - $100,000 | 0.4% | |
| Democrat · House | $15,001 - $50,000 | 0.5% | |
| Democrat · House | $1,001 - $15,000 | 1.6% |
The largest estimated position is in the $100,001 - $250,000 band. Estimate, as of Nov 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
Data as of Nov 11, 2026.
What the filings on CTAS show and how current they are.
Across the 3 most recent open-market filings shown here, 0 were purchases and 3 were sales.
Ro Khanna, Lisa C. McClain, Val T. Hoyle and Jefferson Shreve disclosed CTAS transactions in the filings shown here.
4 members of Congress report a position in CTAS in the estimate we hold as of Nov 10, 2026. The three largest estimated positions belong to Rick W. Allen, Robert Bresnahan and Lucy McBath. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Cintas Corporation is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Nov 11, 2026. Current members of either index get a page here whatever their filing history.
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.